Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 12/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.71 |
| ▸ | USP2 | O75604 | 2/20 | 0.71 |
| ▸ | MLNR | O43193 | 4/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.44 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALB | P02768 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleandomycin SCHEMBL3717 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNAABCB1USP2MLNR | |
| Oleandomycin SCHEMBL29684259 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNAABCB1USP2MLNR | |
| Oleandomycin SCHEMBL10028439 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNAABCB1USP2MLNR | |
| Oleandomycin SCHEMBL9807053 | 0.99 | CYP3A4 (0.99) | CYP3A4LMNAABCB1USP2MLNR | |
| Oleandomycin SCHEMBL950913 | 0.98 | CYP3A4 (0.96) | CYP3A4LMNAABCB1USP2MLNR | |
| Oleandomycin SCHEMBL5033021 | 0.97 | CYP3A4 (1.00) | CYP3A4LMNAABCB1USP2MLNR | |
| Oleandomycin SCHEMBL285338 | 0.97 | CYP3A4 (1.00) | CYP3A4LMNAABCB1USP2MLNR | |
| SCHEMBL11029029 | 0.92 | CYP3A4 (0.85) | CYP3A4LMNAABCB1USP2MLNR | |
| Diproleandomycin SCHEMBL2109038 | 0.87 | CYP3A4 (0.78) | CYP3A4LMNAABCB1USP2MLNR | |
| SCHEMBL5551907 | 0.86 | CYP3A4 (0.74) | CYP3A4LMNAABCB1USP2MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8673 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139860-A1 | PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS | CENTRE FOR DIGESTIVE DISEASES (AU) | 2026-05-21 | — | — | US | claimed |
| US-12616708-B2 | Methods for treating pulmonary non-tuberculous mycobacterial infections | INSMED INCORPORATED (US) | 2026-05-05 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20260034154-A1 | METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS | INSMED INCORPORATED (US) | 2026-02-05 | — | — | US | claimed |
| EP-4680248-A1 | PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM | Topelia Aust Limited (ACN 652 771 670) (AU) | 2026-01-21 | — | — | EP | claimed |
| EP-4673157-A2 | COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND USING SAME | Persephone Biosciences, Inc. (US) | 2026-01-07 | — | — | EP | claimed |
| WO-2025264805-A2 | SYNBIOTICS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND USING SAME | PERSEPHONE BIOSCIENCES, INC. (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| US-20250325574-A1 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | INSMED INCORPORATED (US) | 2025-10-23 | — | — | US | claimed |
| US-4429116-A | Alkylated oleandomycin containing compounds | PFIZER INC. (US) | 1984-01-31 | — | — | US | claimed |
| US-4414204-A | WITH A MURAMYL-PEPTIDE | CIBA-GEIGY CORPORATION (US) | 1983-11-08 | — | — | US | claimed |
| EP-0088943-A2 | Composition for the resorption of injected antibacterial substances and mixtures containing a benzyl amine derivative | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 1983-09-21 | — | — | EP | claimed |
| EP-0087915-A1 | Semi-synthetic oleandomycins and erythromycins | PFIZER INC. (US) | 1983-09-07 | — | — | EP | claimed |
| EP-0056290-A2 | Novel macrolidic antibiotics having antibiotic activity, process and microorganism for their preparation, and related pharmaceutical compositions | Pierrel S.p.A. (IT) | 1982-07-21 | — | — | EP | claimed |
| EP-0041114-A2 | Process for the preparation of medicated animal feed supplement | AMERICAN CYANAMID COMPANY (US) | 1981-12-09 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| EP-0032304-A1 | Antibiotic compositions | ELI LILLY AND COMPANY (US) | 1981-07-22 | — | — | EP | claimed |
| US-4239750-A | CHICKENS AND PIGS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1980-12-16 | — | — | US | claimed |
| EP-0019809-A1 | Animal feed mixture | Henkel Kommanditgesellschaft auf Aktien (DE) | 1980-12-10 | — | — | EP | claimed |